
OLD Category: signatures
November 21, 2020 / iScience
SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations
November 20, 2020 / Cancers
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
November 20, 2020 / Oncologist
Molecular Profiling of Exceptional Responders to Cancer Therapy
November 19, 2020 / Front Oncol
Immune Adaptation of Colorectal Cancer Stem Cells and Their Interaction With the Tumor Microenvironment
November 18, 2020 / Cancer Immunol Immunother
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy
November 18, 2020 / Ann Surg Oncol
Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma
November 17, 2020 / J Korean Med Sci
Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children
November 16, 2020 / Clin Cancer Res
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
November 16, 2020 / Thorac Cancer
Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer
November 16, 2020 / Am J Transl Res
The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy
November 13, 2020 / Clin Orthop Relat Res